{"id":"NCT00255164","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis","officialTitle":"A Phase 3 Study to Evaluate the Safety and Efficacy of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2006-11","completion":"2006-11","firstPosted":"2005-11-17","resultsPosted":"2009-08-28","lastUpdate":"2012-02-03"},"enrollment":451,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Esophagitis, Reflux","Esophagitis, Peptic"],"interventions":[{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dexlansoprazole MR 60 mg QD","type":"EXPERIMENTAL"},{"label":"Dexlansoprazole MR 90 mg QD","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the ability of once-daily (QD) treatment with Dexlansoprazole modified-release (MR) 60 mg and 90 mg and placebo in maintaining healing of erosive esophagitis (EE).","primaryOutcome":{"measure":"Percentage of Subjects Who Maintained Complete Healing of Erosive Esophagitis as Assessed by Endoscopy - Crude Rate Analysis.","timeFrame":"6 months","effectByArm":[{"arm":"Placebo QD","deltaMin":14.3,"sd":null},{"arm":"Dexlansoprazole MR 60 mg QD","deltaMin":66.4,"sd":null},{"arm":"Dexlansoprazole MR 90 mg QD","deltaMin":64.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.00001"},{"comp":"OG000 vs OG002","p":"<0.00001"},{"comp":"OG001 vs OG002","p":"0.80473"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":96,"countries":["United States"]},"refs":{"pmids":["19681809","19735233","20195905"],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=9efb34b3-fb69-4190-a2be-a90b8cb94e25&filetypecode=DEXILANTPI"]},"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Diarrhoea (Excluding [Excl] Infective)","Gastrointestinal and Abdominal Pains (Excl Oral and Throat)","Gastritis (Excl Infective)","Upper Respiratory Tract Infections","Flatulence, Bloating and Distension"]}}